References:
1. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507. 2. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec; 281(3):730-736. 3. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun; 271(3):655-63. 4. Bernardi D, Macaskill P, Pellegrini M, et al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13. 5. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737 43. 6. Rocha Garcia, A.M., Mera Fernandez, D. Breast tomosynthesis: State of the art. Radiologia. 2019;61(4):274-285 7. Heywang Köbrunner SH, Jänsch A, Hacker A, et al. Digital breast tomosynthesis (DBT) plus synthesised two dimensional mammography (s2D) in breast cancer screening is associated with higher cancer detection and lower recalls compared to digital mammography (DM) alone: results of a systematic review and meta analysis. European Radiology 2021 Oct 25; https://doi.org/10.1007/s00330-021-08308-10 [nam12.safelinks.protection.outlook.com]. 8. DHM-06039 Rev 002 Bartoshevich J, Orefice T, Mansoor S, et.al Internal Study comparing Hologic’s flat paddle to the SmartCurve paddle (18x24cm) (2017).
References: 1*Data on file.
**When Clarity HD high-resolution 3D™ imaging is used in combination with the optional Intelligent 2D™ imaging technology license on SecurView® workstations.
Results from Friedewald, SM, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 311.24 (2014): 2499-2507; a multi site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia® Dimensions® on screening outcomes. Individual results may vary. The study found an average 41% increase and that 2 (95% CI: 0.8 1.6) additional invasive breast cancers per 1,000 screening exams were found in women receiving combined 2D FFDM and 3D™ mammograms acquired with the Hologic 3D Mammography™ System versus women receiving 2D FFDM mammograms only.
The Genius 3D Mammography™ exam (a.k.a. Genius exam) is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set.
The Genius exam is only available on the Hologic® 3D Mammography™ system.
Please consult your physician for a full list of benefits and risks associated with mammography.